The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott | Common | 002824100 | 18,189,223 | 166,843 | SH | SOLE | 166,843 | 0 | 0 | ||
Abbvie | Common | 00287Y109 | 25,833,534 | 191,743 | SH | SOLE | 191,743 | 0 | 0 | ||
Allstate | Common | 020002101 | 18,192,669 | 166,844 | SH | SOLE | 166,844 | 0 | 0 | ||
Uhaul | Common | 023586100 | 4,136,692 | 74,764 | SH | SOLE | 74,764 | 0 | 0 | ||
Uhaul B | Common | 023586506 | 32,455,655 | 640,530 | SH | SOLE | 640,530 | 0 | 0 | ||
Apple | Common | 037833100 | 11,402,101 | 58,801 | SH | SOLE | 58,801 | 0 | 0 | ||
Ashland | Common | 044209104 | 1,303,350 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
Avista | Common | 05379B107 | 8,050,350 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
Caribu Biosciences | Common | 142038108 | 850,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CMS Energy | Common | 125896100 | 24,484,356 | 416,755 | SH | SOLE | 416,755 | 0 | 0 | ||
Acorda Theraputics | Cv 6.0% | 00484MAB2 | 3,272,500 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | ||
Accelerate Diagnostic | Cv 5.0% | 00430HAC6 | 3,055,000 | 3,055,000 | PRN | SOLE | 3,055,000 | 0 | 0 | ||
Duke Energy | Common | 26441C204 | 23,361,027 | 260,319 | SH | SOLE | 260,319 | 0 | 0 | ||
EDAP | Common | 268311107 | 5,243,594 | 565,652 | SH | SOLE | 565,652 | 0 | 0 | ||
Fate Theraputics | Common | 31189P102 | 956,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AT & T | Common | 00206R102 | 17,868,051 | 1,120,254 | SH | SOLE | 1,120,254 | 0 | 0 | ||
Warner Bros. Discovery | Common | 934423104 | 185,581 | 14,811 | SH | SOLE | 14,811 | 0 | 0 | ||
Nextera Energy | Common | 302571104 | 25,600,556 | 345,114 | SH | SOLE | 345,114 | 0 | 0 | ||
Kodiak Sciences | Common | 50015M109 | 3,258,970 | 473,000 | SH | SOLE | 473,000 | 0 | 0 | ||
Personalis | Common | 71535D106 | 279,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
908 Devices | Common | 65443P102 | 467,076 | 68,286 | SH | SOLE | 68,286 | 0 | 0 | ||
Lava Theraputics | Common | N51517105 | 1,566,904 | 771,874 | SH | SOLE | 771,874 | 0 | 0 | ||
Newmont | Common | 651639106 | 2,798,496 | 65,600 | SH | SOLE | 65,600 | 0 | 0 | ||
IGM Bioscience | Common | 449585108 | 506,550 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
Insteel | Common | 45774W108 | 10,687,323 | 343,423 | SH | SOLE | 343,423 | 0 | 0 | ||
Organon | Common | 68622V106 | 654,890 | 31,470 | SH | SOLE | 31,470 | 0 | 0 | ||
Mannkind | Common | 56400P706 | 791,996 | 195,073 | SH | SOLE | 195,073 | 0 | 0 | ||
Merck | Common | 589331107 | 34,659,925 | 300,372 | SH | SOLE | 300,372 | 0 | 0 | ||
Paratek | Cv 4.75% | 699374AA2 | 16,268,000 | 16,600,000 | PRN | SOLE | 16,600,000 | 0 | 0 | ||
Paratek | Common | 699374302 | 3,439,305 | 1,556,247 | SH | SOLE | 1,556,247 | 0 | 0 | ||
Pfizer | Common | 717081103 | 19,756,801 | 538,626 | SH | SOLE | 538,626 | 0 | 0 | ||
RLI | Common | 749607107 | 327,576 | 2,400 | SH | SOLE | 2,400 | 0 | 0 | ||
Supernus | Common | 868459108 | 2,468,076 | 82,105 | SH | SOLE | 82,105 | 0 | 0 | ||
Viatris | Common | 92556V106 | 594,199 | 59,539 | SH | SOLE | 59,539 | 0 | 0 | ||
Bausch Health | Common | 91911K102 | 7,415,497 | 925,780 | SH | SOLE | 925,780 | 0 | 0 | ||
XM Sirius | Common | 82968B103 | 2,993,185 | 657,843 | SH | SOLE | 657,843 | 0 | 0 | ||
XEL Energy | Common | 98389B100 | 23,115,663 | 371,754 | SH | SOLE | 371,754 | 0 | 0 |